BPIL1 antibody
Principal name
BPIL1 antibody
Alternative names for BPIL1 antibody
RYSR, C20orf184, LPLUNC2, Long palate, lung and nasal epithelium carcinoma-associated protein 2, Bactericidal/permeability-increasing protein-like 1
Ncbi ID
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P)
Background of BPIL1 antibody
- Kit Component:
- - KN302236G1, Bpifb2 gRNA vector 1 in pCas-Guide vector
- KN302236G2, Bpifb2 gRNA vector 2 in pCas-Guide vector
- KN302236D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Western blot analysis of anti-BPIL1 Antibody (N-term) Cat.-No AP14072PU-N in SK-BR-3 cell line lysates (35ug/lane). BPIL1 (arrow) was detected using the purified Pab.
Predicted band size: 49 kDa . Positive control: Human lung tissue lysate. Recommended dilution: 1/1000-5000
Predicted cell location: Cytoplasm. Positive control: Human breast cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded Human breast cancer tissue using BPIFB2 antibody at dilution 1/50, on the right is treated with the synthetic peptide. (Original magnification: x200)
Predicted cell location: Cytoplasm. Positive control: Human liver and lung cancer tissue. Recommended dilution: 1/50-200 The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using BPIFB2 antibody at dilution 1/45, on the right is treated with the synthetic peptide. (Original magnification:x 200)
Predicted cell location: Cytoplasm. Positive control: Human liver and lung cancer tissue. Recommended dilution: 1/50-200 The image on the left is immunohistochemistry of paraffin-embedded Human lung cancer tissue using BPIFB2 antibody at dilution 1/45, on the right is treated with the synthetic peptide. (Original magnification: x200)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA322168 | BPIL1 antibody |
||||||
| Anti-BPIFB2 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| TA322169 | BPIL1 antibody |
||||||
| Anti-BPIFB2 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| AP14072PU-N | BPIL1 (N-term) antibody |
||||||
 |
Rabbit | Ig | Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY410773 | BPIFB2 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR212731L2V | Lenti ORF particles, Bpifb2 (GFP-tagged) - Mouse bactericidal/permeability-increasing protein-like 1 (Bpil1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,140.00
|
|
| OriGene Technologies, Inc. | ||
| MR212731L1V | Lenti ORF particles, Bpifb2 (Myc-DDK-tagged) - Mouse bactericidal/permeability-increasing protein-like 1 (Bpil1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,020.00
|
|
| OriGene Technologies, Inc. | ||
